CMS Proposes Prior Authorization Standards, Stricter Transparency Requirements for Drugs
- April 17, 2026
- Written by AHLA Legal Staff
The Centers for Medicare & Medicaid Services (CMS) is moving to ensure a streamlined prior authorization process for drugs that includes strengthened transparency requirements for denials and appeals under a proposed rule (91 Fed. Reg. 19890) published April 14.
ARTICLE TAGS
You must be logged in to access this content.